Cargando…

Incidence, Clinical Presentation and Trends in Indication for Diagnostic Work-Up of Small Intestinal and Pancreatic Neuroendocrine Tumors

Background: The incidence of small intestinal (SI) and pancreatic neuroendocrine tumors (siNETs and pNETs) seems to have increased. The increased frequency of incidental findings might be a possible explanation. The study aimed to examine (1) changes in incidence and the stage at diagnosis (2010–201...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stensbøl, Anna Bryan, Krogh, Jesper, Holmager, Pernille, Klose, Marianne, Oturai, Peter, Kjaer, Andreas, Hansen, Carsten Palnæs, Federspiel, Birgitte, Langer, Seppo W., Knigge, Ulrich, Andreassen, Mikkel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8624499/ https://www.ncbi.nlm.nih.gov/pubmed/34829377 http://dx.doi.org/10.3390/diagnostics11112030

Ejemplares similares

Limited Diagnostic Utility of Chromogranin A Measurements in Workup of Neuroendocrine Tumors
por: Baekdal, Jonas, et al.
Publicado: (2020)

Topotecan Monotherapy in Heavily Pretreated Patients with Progressive Advanced Stage Neuroendocrine Carcinomas
por: Olsen, Ingrid Holst, et al.
Publicado: (2014)

Temozolomide as Second or Third Line Treatment of Patients with Neuroendocrine Carcinomas
por: Olsen, Ingrid H., et al.
Publicado: (2012)

Neuroendocrine Carcinomas of the Gastroenteropancreatic System: A Comprehensive Review
por: Ilett, Emma Elizabeth, et al.
Publicado: (2015)

P53, Somatostatin receptor 2a and Chromogranin A immunostaining as prognostic markers in high grade gastroenteropancreatic neuroendocrine neoplasms
por: Nielsen, Kirstine, et al.
Publicado: (2020)

Cowden Syndrome and Concomitant Pulmonary Neuroendocrine Tumor: A Presentation of Two Cases
por: Langer, Seppo W., et al.
Publicado: (2015)

Initial Experience with (64)Cu-DOTATATE Digital PET of Patients with Neuroendocrine Neoplasms: Comparison with Analog PET
por: Loft, Mathias, et al.
Publicado: (2021)

Intrapancreatic accessory spleen mimicking malignant tumor: three case reports
por: Zurek Munk-Madsen, Maria, et al.
Publicado: (2019)

Somatostatin Analogue Treatment Primarily Induce miRNA Expression Changes and Up-Regulates Growth Inhibitory miR-7 and miR-148a in Neuroendocrine Cells
por: Døssing, Kristina B. V., et al.
Publicado: (2018)

Gene Expression of Glucose Transporter 1 (GLUT1), Hexokinase 1 and Hexokinase 2 in Gastroenteropancreatic Neuroendocrine Tumors: Correlation with F-18-fluorodeoxyglucose Positron Emission Tomography and Cellular Proliferation
por: Binderup, Tina, et al.
Publicado: (2013)

A convolutional neural network for total tumor segmentation in [(64)Cu]Cu-DOTATATE PET/CT of patients with neuroendocrine neoplasms
por: Carlsen, Esben Andreas, et al.
Publicado: (2022)

Alternative Polyadenylation of Tumor Suppressor Genes in Small Intestinal Neuroendocrine Tumors
por: Rehfeld, Anders, et al.
Publicado: (2014)

Use of radioactive substances in diagnosis and treatment of neuroendocrine tumors
por: Kjaer, Andreas, et al.
Publicado: (2015)

Down-Regulation of miR-129-5p and the let-7 Family in Neuroendocrine Tumors and Metastases Leads to Up-Regulation of Their Targets Egr1, G3bp1, Hmga2 and Bach1
por: Døssing, Kristina B. V., et al.
Publicado: (2014)

Solid pseudopapillary neoplasm of the pancreas: Clinical-pathological features and management, a single-center experience
por: Hansen, Carsten Palnaes, et al.
Publicado: (2019)

PD-L1 expression in gastroenteropancreatic neuroendocrine neoplasms grade 3
por: Ali, Abir Salwa, et al.
Publicado: (2020)

Expression of p53 protein in high-grade gastroenteropancreatic neuroendocrine carcinoma
por: Ali, Abir Salwa, et al.
Publicado: (2017)

Goblet Cell Carcinoids: Characteristics of a Danish Cohort of 83 Patients
por: Olsen, Ingrid Holst, et al.
Publicado: (2015)

Hitherto unseen survival in an ALK‐positive‐patient with advanced stage adult ganglioneuroblastoma treated with personalized medicine
por: Risum, Signe, et al.
Publicado: (2017)

Pituitary function after transsphenoidal surgery including measurement of basal morning cortisol as predictor of adrenal insufficiency
por: Staby, Ida, et al.
Publicado: (2021)

(18)F-FDG and (18)F-FLT-PET Imaging for Monitoring Everolimus Effect on Tumor-Growth in Neuroendocrine Tumors: Studies in Human Tumor Xenografts in Mice
por: Bardram Johnbeck, Camilla, et al.
Publicado: (2014)

Metabolic effects of dopamine agonists in patients with prolactinomas: a systematic review and meta-analysis
por: Byberg, Sarah, et al.
Publicado: (2019)

Variation in serum adrenal hormones in female 21-hydroxylase deficient patients
por: Sørensen, Ditte Sofie Dahl, et al.
Publicado: (2022)

Intravenous versus oral etoposide: efficacy and correlation to clinical outcome in patients with high-grade metastatic gastroenteropancreatic neuroendocrine neoplasms (WHO G3)
por: Ali, Abir Salwa, et al.
Publicado: (2018)

Science in the clinic: a qualitative study of the positioning of MD-PhDs in the everyday clinical setting
por: Andreassen, Pernille, et al.
Publicado: (2018)

Induction of Anti-Tumor Immune Responses by Peptide Receptor Radionuclide Therapy with (177)Lu-DOTATATE in a Murine Model of a Human Neuroendocrine Tumor
por: Wu, Yin, et al.
Publicado: (2013)

Plasma protein biomarkers for the detection of pancreatic neuroendocrine tumors and differentiation from small intestinal neuroendocrine tumors
por: Thiis‐Evensen, Espen, et al.
Publicado: (2022)

Danish Pancreatic Cancer Database
por: Fristrup, Claus, et al.
Publicado: (2016)

Endoscopic Ultrasound-Guided Drainage of a Pancreatic Pseudocyst after a Bicycle Trauma
por: Grossjohann, Hanne Soender, et al.
Publicado: (2019)

microRNA-146a inhibits G protein-coupled receptor-mediated activation of NF-κB by targeting CARD10 and COPS8 in gastric cancer
por: Crone, Stephanie Geisler, et al.
Publicado: (2012)

The results of pancreatic surgery in Inuit patients from Greenland 1999-2022
por: Almdal, Kerstin, et al.
Publicado: (2023)

A Randomized, Factorial Phase II Study to Determine the Optimal Dosing Regimen for (68)Ga-Satoreotide Trizoxetan as an Imaging Agent in Patients with Gastroenteropancreatic Neuroendocrine Tumors
por: Virgolini, Irene, et al.
Publicado: (2022)

Site‐specific trends in gastroenteropancreatic neuroendocrine neoplasms in Bavaria, Germany
por: Grundmann, Nina, et al.
Publicado: (2023)

Expression Patterns and Correlations with Metabolic Markers of Zinc Transporters ZIP14 and ZNT1 in Obesity and Polycystic Ovary Syndrome
por: Maxel, Trine, et al.
Publicado: (2017)

Biliary Leakage Following Pancreatoduodenectomy: Experience from a High-Volume Center
por: Farooqui, Waqas, et al.
Publicado: (2021)

First-in-Human Study of [(68)Ga]Ga-NODAGA-E[c(RGDyK)](2) PET for Integrin α(v)β(3) Imaging in Patients with Breast Cancer and Neuroendocrine Neoplasms: Safety, Dosimetry and Tumor Imaging Ability
por: Clausen, Malene Martini, et al.
Publicado: (2022)

Temporal trends in cause-specific mortality in a rural-provincial area of Denmark, Lolland-Falster, 1970–2018
por: Holmager, Therese Lucia Friis, et al.
Publicado: (2022)

Diabetes and ischemic heart disease: double jeopardy with regard to depressive mood and reduced quality of life
por: Bergmann, Natasha, et al.
Publicado: (2014)

miR-449 inhibits cell proliferation and is down-regulated in gastric cancer
por: Bou Kheir, Tony, et al.
Publicado: (2011)

Urban versus rural residency and pancreatic cancer survival: A Danish nationwide population-based cohort study
por: Kirkegård, Jakob, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4i65lf02atdn82d570fevachho